The House Dec. 12 voted 386-37 to pass AHA-supported legislation (H.R. 4531) that would reauthorize key SUPPORT Act programs for patients with substance use disorder and permanently extend required Medicaid coverage for medication-assisted treatments. The Senate Health, Education, Labor & Pensions Committee today advanced its own SUPPORT Act reauthorization bill (S. 3393). In comments  submitted to the committee, AHA voiced support for provisions in the Senate bill that would reauthorize grants to help states enhance the collection of overdose data and improve their prescription drug monitoring programs, and require agencies to finalize regulations for prescribing controlled substances over telemedicine, among other proposals.  

Related News Articles

Headline
The House Energy and Commerce Committee June 12 passed AHA-supported legislation during a markup of bills that passed the Health Subcommittee in May. The…
Headline
The AHA praised House and Senate leaders in letters June 12 for reintroducing the Improving Seniors’ Timely Access to Care Act, bipartisan legislation that…
Headline
The Medicaid and CHIP Payment and Access Commission (MACPAC) June 11 released its June report to Congress. The first chapter focuses on improving the…
Headline
Chris DeRienzo, M.D., AHA senior vice president and chief physician executive, speaks with three experts about how the award-winning Women and Infant Substance…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Headline
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent…